Classification of genes and putative biomarker identification using distribution metrics on expression profiles

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Huang, Hung Chung ^a   Jupiter, Daniel ^a   VanBuren, Vincent ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN; CORRELATION COEFFICIENT; DISEASE MARKER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SWITCHING; KOLMOGOROV SMIRNOV TEST; MOUSE; NONHUMAN; ALGORITHM; ANIMAL; BIOLOGICAL MODEL; BIOLOGY; CLASSIFICATION; CLUSTER ANALYSIS; COMPUTER PROGRAM; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; HEART; HEART MUSCLE; METABOLISM; PRENATAL DEVELOPMENT; STATISTICS;

ALGORITHMS; ANIMALS; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HEART; MICE; MODELS, GENETIC; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; SOFTWARE;

EID: 77949350027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009056     Document Type: Article

References (87)

1. Angeli D, Ferrell JE Jr, Sontag ED (2004) Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci U S A 101: 1822-1827.
2. Kaznessis YN (2007) Models for synthetic biology. BMC Syst Biol 2007 1: 47.
3. Ingolia NT, Murray AW (2007) Positive-feedback loops as a flexible biological module. Curr Biol 17: 668-677.
4. Ninfa AJ, Mayo AE (2004) Hysteresis vs. graded responses: the connections make all the difference. Sci STKE 2004: pe20.
5. Pomerening JR, Sontag ED, Ferrell JE Jr (2003) Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat Cell Biol 5: 346-351.
6. Kauffman SA (1969) Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol 22: 437-467.
7. Shmulevich I, Dougherty ER, Kim S, Zhang W (2002) Probabilistic Boolean Networks: a rule-based uncertainty model for gene regulatory networks. Bioinformatics 18: 261-274.
8. Schlitt T, Brazma A (2006) Modelling in molecular biology: describing transcription regulatory networks at different scales. Philos Trans R Soc Lond B Biol Sci 361(1467): 483-494.
9. Schlitt T, Brazma A (2007) Current approaches to gene regulatory network modelling. BMC Bioinformatics 8 Suppl 6: S9.
10. Ruetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, et al. (2005) Identification of CSF biomarkers for frontotemporal dementia using SELDITOF. Exp Neurol 196: 273-281.
11. Wiltfang J, Lewczuk P, Riederer P, Grunblatt E, Hock C, et al. (2005) Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry 6: 69-84.
12. Frankfort SV, Tulner LR, van Campen JP, Verbeek MM, Jansen RW, Beijnen JH (2008) Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr Clin Pharmacol 3: 123-131.
13. Lewczuk P, Wiltfang J (2008) Neurochemical dementia diagnostics: State of the art and research perspectives. Proteomics 8: 1292-1301.
14. Davies NW, Brown LJ, Gonde J, Irish D, Robinson RO, et al. (2005) Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J Neurol Neurosurg Psychiatry 76: 82-87.
15. Choolani M, Narasimhan K, Kolla V, Hahn S (2009) Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Rev Proteomics 6: 87-101.
16. Van den Veyver IB, Patel A, Shaw CA, Pursley AN, Kang SH, et al. (2009) Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn 29: 29-39.
17. Jamjute P, Ahmad A, Ghosh T, Banfield P (2009) Liver function test and pregnancy. J Matern Fetal Neonatal Med 22: 274-283.
18. Lo R, Rye K, Austin A, Freeman J (2009) Screening for liver disease - are LFTs old hat? Curr Med Chem 16: 1442-1450.
19. Chen L, Fatima S, Peng J, Leng X (2009) SELDI protein chip technology for the detection of serum biomarkers for liver disease. Protein Pept Lett 16: 467-472.
20. Lennon S, Barton C, Banken L, Gianni L, Marty M, Baselga J, Leyland-Jones B (2009) Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer. J Clin Oncol 27: 1685-1693.
21. Kotake S, Nanke Y, Yago T, Yamanaka H (2009) [Serum markers of synovitis and bone metabolism in rheumatoid arthritis]. Clin Calcium 19: 362-371.
22. Creaney J, Robinson BW (2009) Serum and pleural fluid biomarkers for mesothelioma. Curr Opin Pulm Med 15: 366-370.
23. Graeber MB (2009) Biomarkers for Parkinson's disease. Exp Neurol 216: 249-253.
24. Jupiter DC, VanBuren V (2008) A visual data mining tool that facilitates reconstruction of transcription regulatory networks. PLoS ONE 3: e1717.
25. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
26. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. (2007) NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res 35: D760-765.
27. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
28. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
29. Gentleman R, Carey V, Huber W, Irizarry RA, Dudoit S (2005) Bioinformatics and computational biology solutions using R and Bioconductor. New York: Springer.
30. Giles PJ, Kipling D (2003) Normality of oligonucleotide microarray data and implications for parametric statistical analyses. Bioinformatics 19: 2254-2262.
31. Rousseeuw PJ (1987) Silhouettes: a Graphical Aid to the Interpretation and Validation of Cluster Analysis. Computational and Applied Mathematics 20: 53-65.
32. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748.
33. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. (2009) NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 37: D885-890.
34. Chakravarti IM, Laha RG, Roy J (1967) Handbook of Methods of Applied Statistics, vol. I. New York: John Wiley and Sons 160.
35. Stephens MA (1974) EDF Statistics for Goodness of Fit and Some Comparisons. Journal of the American Statistical Association 69: 730-737.
36. Cohen J, Cohen P, West SG, Aiken LS (2002) Applied multiple regression/correlation analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates 736.
37. Rodgers JL, Nicewander WA (1988) Thirteen ways to look at the correlation coefficient. The American Statistician 42: 59-66.
38. Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, et al. (2008) Interaction between the coagulation and complement system. Adv Exp Med Biol 632: 71-79.
39. Das UN (2006) Essential Fatty acids - a review. Curr Pharm Biotechnol 7: 467-482.
40. Das UN (2006) Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 1: 420-439.
41. Calder PC (2006) Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75: 197-202.
42. El-Badry AM, Graf R, Clavien PA (2007) Omega 3 - Omega 6: What is right for the liver? J Hepatol 47: 718-725.
43. Cunnane SC, Anderson MJ (1997) Pure linoleate deficiency in the rat: influence on growth, accumulation of n-6 polyunsaturates, and [1-14C]linoleate oxidation. J Lipid Res 38: 805-812.
44. Massoumi R, Sjolander A (2007) The role of leukotriene receptor signaling in inflammation and cancer. ScientificWorldJournal 7: 1413-1421.
45. Khanapure SP, Garvey DS, Janero DR, Letts LG (2007) Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem 7: 311-340.
46. Boyce JA (2008) Eicosanoids in asthma, allergic inflammation, and host defense. Curr Mol Med 8: 335-349.
47. Phillis JW, Horrocks LA, Farooqui AA (2006) Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 52: 201-243.
48. Reid RC (2005) Inhibitors of secretory phospholipase A2 group IIA. Curr Med Chem 12: 3011-3026.
49. Ma B, Nussinov R (2009) Amplification of signaling via cellular allosteric relay and protein disorder. Proc Natl Acad Sci U S A 106: 6887-6888.
50. Dickson BJ (2002) Molecular mechanisms of axon guidance. Science 298: 1959-1964.
51. Killeen MT, Sybingco SS (2008) Netrin, Slit and Wnt receptors allow axons to choose the axis of migration. Dev Biol 323: 143-151.
52. Bernet A, Fitamant J (2008) Netrin-1 and its receptors in tumour growth promotion. Expert Opin Ther Targets 12: 995-1007.
53. Lai KO, Ip NY (2009) Synapse development and plasticity: roles of ephrin/Eph receptor signaling. Curr Opin Neurobiol 19: 275-283.
54. Klein R (2009) Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat Neurosci 12: 15-20.
55. Negishi M, Oinuma I, Katoh H (2005) Plexins: axon guidance and signal transduction. Cell Mol Life Sci 62: 1363-1371.
56. Brose K, Tessier-Lavigne M (2000) Slit proteins: key regulators of axon guidance, axonal branching, and cell migration. Curr Opin Neurobiol 10: 95-102.
57. Mann F, Harris WA, Holt CE (2004) New views on retinal axon development: a navigation guide. Int J Dev Biol 48: 957-964.
58. McLaughlin T, O'Leary DD (2005) Molecular gradients and development of retinotopic maps. Annu Rev Neurosci 28: 327-355.
59. Scales SJ, de Sauvage FJ (2009) Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 30: 303-312.
60. Jenkins D (2009) Hedgehog signalling: emerging evidence for non-canonical pathways. Cell Signal 21: 1023-1034.
61. Simpson F, Kerr MC, Wicking C (2009) Trafficking, development and hedgehog. Mech Dev 126: 279-288.
62. Sheng T, Li C, Zhang X, Chi S, He N, et al. (2004) Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 3: 29.
63. Pasca di Magliano M, Sekine S, Ermilov A, Ferris J, Dlugosz AA, Hebrok M (2006) Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 20: 3161-3173.
64. Yang SH, Andl T, Grachtchouk V, Wang A, Liu J, et al. (2008) Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/(E≤-catenin signaling. Nat Genet 40: 1130-1135.
65. Barginear MF, Leung M, Budman DR (2009) The hedgehog pathway as a therapeutic target for treatment of breast cancer. Breast Cancer Res Treat 116: 239-246.
66. Medina V, Calvo MB, Diaz-Prado S, Espada J (2009) Hedgehog signalling as a target in cancer stem cells. Clin Transl Oncol 11: 199-207.
67. Bosanac I, Maun HR, Scales SJ, Wen X, Lingel A, et al. (2009) The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling. Nat Struct Mol Biol 16: 691-697.
68. Akabas MH (1990) Mechanisms of chemosensory transduction in taste cells. Int Rev Neurobiol 32: 241-279.
69. Meyers B, Brewer MS (2008) Sweet taste in man: a review. J Food Sci 73: R81-90.
70. Yasuo T, Kusuhara Y, Yasumatsu K, Ninomiya Y (2008) Multiple receptor systems for glutamate detection in the taste organ. Biol Pharm Bull 31: 1833-1837.
71. Sugita M (2006) Taste perception and coding in the periphery. Cell Mol Life Sci 63: 2000-2015.
72. DeSimone JA, Ye Q, Heck GL (1993) Ion pathways in the taste bud and their significance for transduction. Ciba Found Symp. pp 179-218-229; discussion 229-234.
73. Heidelberger R (2007) Mechanisms of tonic, graded release: lessons from the vertebrate photoreceptor. J Physiol 585: 663-667.
74. Bourque CW, Ciura S, Trudel E, Stachniak TJ, Sharif-Naeini R (2007) Neurophysiological characterization of mammalian osmosensitive neurones. Exp Physiol 92: 499-505.
75. Singer JH (2007) Multivesicular release and saturation of glutamatergic signalling at retinal ribbon synapses. J Physiol 580: 23-29.
76. Biscoe TJ, Duchen MR (1990) Cellular basis of transduction in carotid chemoreceptors. Am J Physiol 258: L271-278.
77. Ertel A, Tozeren A (2008) Switch-like genes populate cell communication pathways and are enriched for extracellular proteins. BMC Genomics 9: 3.
78. Ertel A, Tozeren A (2008) Human and mouse switch-like genes share common transcriptional regulatory mechanisms for bimodality. BMC Genomics 9: 628.
79. Laterza OF, Modur VR, Crimmins DL, Olander JV, Landt Y, et al. (2006) Identification of novel brain biomarkers. Clin Chem 52: 1713-1721.
80. Veleiro AS, Burton G (2009) Structure-activity relationships of neuroactive steroids acting on the GABAA receptor. Curr Med Chem 16: 455-472.
81. Mody I (2008) Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol. Neurochem Int 52: 60-64.
82. Huang ZJ (2006) GABAB receptor isoforms caught in action at the scene. Neuron 50: 521-524.
83. Bettler B, Tiao JY (2006) Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacol Ther 110: 533-543.
84. Rajendra S, Lynch JW, Schofield PR (1997) The glycine receptor. Pharmacol Ther 73: 121-146.
85. Lynch JW (2004) Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84: 1051-1095.
86. Palmada M, Centelles JJ (1998) Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain. Front Biosci 3: d701-718.
87. Tang FR, Bradford HF, Ling EA (2009) Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs. Curr Med Chem 16: 2189-2204.